Search Results - "Meisel, Andreas"

Summary of Research: Terminal Complement Inhibitor Ravulizumab in Generalized Myasthenia Gravis.

Authors: Vu, Tuan Meisel, Andreas Mantegazza, Renato et al.

Source: Neurology & Therapy. Oct2023, Vol. 12 Issue 5, p1435-1438. 4p.

The crux of NPO paradox revealed by increased pneumonia incidence in post-stroke dysphagia patients with dietary restrictions.

Authors: Ihrke, Manuela Meisel, Andreas Nelde, Alexander et al.

Source: Scientific Reports. 10/3/2025, Vol. 15 Issue 1, p1-13. 13p.

Prediction of Myasthenia Gravis Worsening: A Machine Learning Algorithm Using Wearables and Patient‐Reported Measures.

Authors: Stein, Maike Sun, Haoqi Lehnerer, Sophie et al.

Source: Annals of Clinical & Translational Neurology. Apr2026, Vol. 13 Issue 4, p714-723. 10p.

Reply to Letter: "Limitations of Complement Activity Assays as Biomarkers for Ravulizumab Therapeutic Monitoring" by Saccà and Pelto Regarding "Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab".

Authors: Gerischer, Lea Schroeder‐Braunstein, Jutta Wabnitz, Guido et al.

Source: Annals of Clinical & Translational Neurology. Jun2026, Vol. 13 Issue 6, p1303-1304. 2p.

Remote Monitoring in Myasthenia Gravis: Exploring Symptom Variability.

Authors: Stein, Maike Mönch, Maximilian Herdick, Meret et al.

Source: Annals of Clinical & Translational Neurology. Jun2026, Vol. 13 Issue 6, p1106-1117. 12p.

Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab.

Authors: Gerischer, Lea Stascheit, Frauke Mönch, Maximilian et al.

Source: Annals of Clinical & Translational Neurology. Apr2026, Vol. 13 Issue 4, p688-699. 12p.

Blood biomarker changes following therapeutic hypothermia in ischemic stroke.

Authors: Palà, Elena Penalba, Anna Bustamante, Alejandro et al.

Source: Brain & Behavior. Nov2023, Vol. 13 Issue 11, p1-7. 7p.

The European Lambert–Eaton Myasthenic Syndrome Registry: Long-Term Outcomes Following Symptomatic Treatment.

Authors: Meisel, Andreas Sieb, Jörn P. Le Masson, Gwendal et al.

Source: Neurology & Therapy. Sep2022, Vol. 11 Issue 3, p1071-1083. 13p.

Anti-NMDA-Receptor GluN1 Antibody Serostatus Is Robust in Acute Severe Stroke.

Authors: Sperber, Pia Sophie Hotter, Benjamin Endres, Matthias et al.

Source: Diagnostics (2075-4418). Dec2025, Vol. 15 Issue 24, p3132. 10p.

ADAPT NXT: Fixed Cycles or Every‐Other‐Week IV Efgartigimod in Generalized Myasthenia Gravis.

Authors: Habib, Ali A. Claeys, Kristl G. Bril, Vera et al.

Source: Annals of Clinical & Translational Neurology. Jun2025, Vol. 12 Issue 6, p1162-1170. 9p.

App- and Wearable-Based Remote Monitoring for Patients With Myasthenia Gravis and Its Specialists: Feasibility and Usability Study.

Authors: Stein, Maike Stegherr, Regina Narayanaswami, Pushpa et al.

Source: JMIR Formative Research; 2025, Vol. 9, p1-15, 15p

Anxiety in Myasthenia Gravis Patients Throughout the COVID‐19 Pandemic–Prevalence, Risk Factors, and Association With Vaccination Status.

Authors: Beckmann, Janna Petzold, Moritz Betzler, Felix et al.

Source: Brain & Behavior. Sep2025, Vol. 15 Issue 9, p1-10. 10p.

Recruiting patients into a healthcare services trial: lessons learned from a feasibility study to investigate a patient-oriented navigation intervention for age-associated diseases.

Authors: Gödde, Kathrin Fügemann, Hella Grittner, Ulrike et al.

Source: BMC Health Services Research. 7/2/2025, Vol. 25 Issue 1, p1-13. 13p.

Cost-effectiveness of patient navigation programs for stroke patients–A systematic review.

Authors: Kass, Benjamin Dornquast, Christina Meisel, Andreas et al.

Source: PLoS ONE. 10/15/2021, Vol. 16 Issue 10, p1-12. 12p.

A Primeval Mechanism of Tolerance to Desiccation Based on Glycolic Acid Saves Neurons in Mammals from Ischemia by Reducing Intracellular Calcium‐Mediated Excitotoxicity.

Authors: Chovsepian, Alexandra Berchtold, Daniel Winek, Katarzyna et al.

Source: Advanced Science; 2/3/2022, Vol. 9 Issue 4, p1-19, 19p

Myasthenia gravis - a retrospective analysis of e-mail inquiries made to a patient organisation and specialized center to uncover unmet needs from patients and caregivers.

Authors: Stein, Maike Hoffmann, Sarah Gerischer, Lea et al.

Source: BMC Neurology. 12/7/2022, Vol. 22 Issue 1, p1-8. 8p.

Independent risk factors for myasthenic crisis and disease exacerbation in a retrospective cohort of myasthenia gravis patients.

Authors: Nelke, Christopher Stascheit, Frauke Eckert, Carmen et al.

Source: Journal of Neuroinflammation. 4/12/2022, Vol. 19 Issue 1, p1-12. 12p.

Author Index.

Source: European stroke journal 2025 Suppl 2; Vol. 10.

Journal Info: Publisher: Sage Publications Inc. ISSN: 2396-9873

Author Index.

Source: The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 2025 Supplement 1; Vol. 52 (S1).

Journal Info: Publisher: Cambridge University Press ISSN: 0317-1671

Opposite Regulation of Homer Signal at the NMJ Postsynaptic Micro Domain between Slow- and Fast-Twitch Muscles in an Experimentally Induced Autoimmune Myasthenia Gravis (EAMG) Mouse Model.

Authors: Schubert, Martin Pelz, Andreas Trautmann, Gabor et al.

Source: International Journal of Molecular Sciences. Dec2022, Vol. 23 Issue 23, p15052. 21p.